20 research outputs found

    Catalytic dehydration of cassava-derived glucose into 5-hydroxymethyl-furan (5-HMF) in 1-butyl-3- methylimidazolium chloride ([BMIM]Cl)

    Get PDF
    Catalytic dehydration of glucose and fructose into 5- Hydroxymethylfuran (5-HMF) catalysed by sulfated zirconia in 1- butyl-3-methylimidazolium chloride ([BMIM][Cl]) ionic liquid was investigated by reactive vacuum distillation process. A 5-HMF yields of 82% and 65% were obtained using fructose and glucose substrates in 2 h reaction time at 180 oC. When the reaction time was increased beyond 2 h, a decreased in 5-HMF yield was observed. The ionic liquid and sulfated zirconia exhibited a constant activity when recycled for five successive trials. This process provided an avenue whereby the production of 5-HMF from cassava-derived carbohydrate is conducted and separated with minimal use of volatile solvents.Keywords: Cassava, 5-Hydroxymethylfuran, reactive vacuum distillatio

    Pictet-Spenglerases in Alkaloid Biosynthesis: future applications in Biocatalysis

    Get PDF
    Pictet-Spenglerases provide a key role in the biosynthesis of many biologically-active alkaloids. There is increasing use of these biocatalysts as an alternative to traditional organic synthetic methods as they provide stereoselective and regioselective control under mild conditions. Products from these enzymes also contain privileged drug scaffolds (such as tetrahydroisoquinoline or b-carboline moieties), so there is interest in the characterisation and use of these enzymes as versatile biocatalysts to synthesize analogues of the corresponding natural products for drug discovery. This review discusses all known Pictet- Spenglerase enzymes and their applications as biocatalysts. Rebecca , John M. , Nicholas H. and Helen C.

    'Dopamine-first' mechanism enables the rational engineering of the norcoclaurine synthase aldehyde activity profile

    Get PDF
    Norcoclaurine synthase (NCS) (EC 4.2.1.78) catalyzes the Pictet–Spengler condensation of dopamine and an aldehyde, forming a substituted (S)-tetrahydroisoquinoline, a pharmaceutically important moiety. This unique activity has led to NCS being used for both in vitro biocatalysis and in vivo recombinant metabolism. Future engineering of NCS activity to enable the synthesis of diverse tetrahydroisoquinolines is dependent on an understanding of the NCS mechanism and kinetics. We assess two proposed mechanisms for NCS activity: (a) one based on the holo X-ray crystal structure and (b) the ‘dopamine-first’ mechanism based on computational docking. Thalictrum flavum NCS variant activities support the dopamine-first mechanism. Suppression of the non-enzymatic background reaction reveals novel kinetic parameters for NCS, showing it to act with low catalytic efficiency. This kinetic behaviour can account for the ineffectiveness of recombinant NCS in in vivo systems, and also suggests NCS may have an in planta role as a metabolic gatekeeper. The amino acid substitution L76A, situated in the proposed aldehyde binding site, results in the alteration of the enzyme's aldehyde activity profile. This both verifies the dopamine-first mechanism and demonstrates the potential for the rational engineering of NCS activity

    The acceptance and kinetic resolution of alpha-Methyl Substituted Aldehydes by Norcoclaurine Synthase

    Get PDF
    Norcoclaurine synthase (NCS) catalyzes a stereoselective Pictet-Spengler reaction to give the key intermediate, (S)-norcoclaurine in benzylisoquinoline alkaloid (BIA) biosynthesis. This family of alkaloids contains many bioactive molecules including morphine and berberine. Recently, NCS has been demonstrated to accept a variety of aldehydes and some ketones as substrates, leading to a range of chiral tetrahydroisoquinoline (THIQ) products. Here, we report the unusual acceptance of a-substituted aldehydes, in particular a-methyl substituted aldehydes, by wild-type Thalictrum flavum NCS (Δ33TfNCS) to give THIQ products. Moreover, the kinetic resolution of several a-substituted aldehydes to give THIQs with two defined chiral centers in a single step with high conversions was achieved. Several dopamine analogues were also accepted as substrates and reactions were amenable to scale-up. Active site mutants of TfNCS were then used which demonstrated the potential to enhance the stereoselectivities in the reaction and improve yields. Rationale for the acceptance of these substrates and improved activity with different mutants has been gained from a co-crystallized structure of Δ33TfNCS with a non-productive mimic of a reaction intermediate bound in the active site. Finally, molecular dynamics simulations were performed to study the binding of dopamine and an a-substituted aldehyde and provided further insight into the reaction with these substrates

    Chemoenzymatic cascades toward Methylated Tetrahydroprotoberberine and Protoberberine Alkaloids

    Get PDF
    Tetrahydroprotoberberine and protoberberine alkaloids are a group of biologically active natural products with complex molecular scaffolds. Isolation from plants is challenging and stereoselective synthetic routes, particularly of methylated compounds are limited, reducing the potential use of these compounds. In this work, we describe chemoenzymatic cascades toward various 13-methyl-tetrahydroprotoberberbine scaffolds using a stereoselective Pictet-Spenglerase, regioselective catechol O-methyltransferases and selective chemical Pictet-Spengler reactions. All reactions could be performed sequentially, without the workup or purification of any synthetic intermediates. Moreover, the naturally occurring alkaloids have the (+)-configuration and importantly here, a strategy to the (−)-isomers was developed. A methyl group at C-8 was also introduced with some stereocontrol, influenced by the stereochemistry at C-13. Furthermore, a single step reaction was found to convert tetrahydroprotoberberine alkaloids into the analogous protoberberine scaffold, avoiding the use of harsh oxidizing conditions or a selective oxidase. This work provides facile, selective routes toward novel analogues of bioactive alkaloids
    corecore